GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 97 filers reported holding GENMAB A/S in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,309 | -48.5% | 1,014,533 | -42.2% | 0.05% | -51.9% |
| Q4 2022 | $74,386 | -99.8% | 1,755,217 | +18.2% | 0.10% | +48.6% |
| Q3 2022 | $47,730,000 | +13.5% | 1,485,526 | +14.7% | 0.07% | +16.7% |
| Q2 2022 | $42,065,000 | +33.8% | 1,294,719 | +49.0% | 0.06% | +53.8% |
| Q1 2022 | $31,448,000 | +49.9% | 869,221 | +63.9% | 0.04% | +50.0% |
| Q4 2021 | $20,979,000 | +12.2% | 530,319 | +24.0% | 0.03% | +13.0% |
| Q3 2021 | $18,690,000 | +4667.9% | 427,699 | +4355.2% | 0.02% | – |
| Q2 2021 | $392,000 | -88.0% | 9,600 | -90.4% | 0.00% | -100.0% |
| Q1 2021 | $3,271,000 | -79.1% | 99,633 | -74.2% | 0.00% | -81.8% |
| Q4 2020 | $15,683,000 | -10.7% | 385,700 | -19.6% | 0.02% | -21.4% |
| Q3 2020 | $17,558,000 | -29.0% | 479,595 | -34.3% | 0.03% | -37.8% |
| Q2 2020 | $24,732,000 | +72.1% | 729,769 | +7.6% | 0.04% | +12.5% |
| Q1 2020 | $14,373,000 | +84.2% | 678,302 | +94.1% | 0.04% | +122.2% |
| Q4 2019 | $7,803,000 | +266.5% | 349,422 | +232.5% | 0.02% | +260.0% |
| Q3 2019 | $2,129,000 | – | 105,105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |